Effects of the high-affinity Peptide reversin 121 on multidrug resistance proteins in experimental pancreatic cancer.

Article Details

Citation

Copy to clipboard

Hoffmann K, Bekeredjian R, Schmidt J, Buchler MW, Marten A

Effects of the high-affinity Peptide reversin 121 on multidrug resistance proteins in experimental pancreatic cancer.

Tumour Biol. 2008;29(6):351-8. doi: 10.1159/000178142. Epub 2008 Nov 27.

PubMed ID

19039261 [ View in PubMed

]

Abstract

OBJECTIVES: Multidrug resistance (MDR) is the major obstacle in the treatment of pancreatic carcinoma. Recent studies indicate resistance-modulating effects of high-affinity peptides. MATERIAL AND METHODS: Pancreatic cancer was induced in an ultrasound-guided orthotopic mouse model. Expression and function of MDR proteins (MRPs) P-glycoprotein MRP1 and MRP3 were analyzed in vitroandin vivo by multicolor flow-cytometric analysis. Proliferation of tumor cells was evaluated with a nonradioactive proliferation assay. Animals and cells received standard chemotherapy or chemotherapy plus the high-affinity peptide reversin 121 (R121). RESULTS: The proportions of P-glycoprotein-, MRP1- and MRP3-positive tumor cells increased significantly after chemotherapy in vitro and in vivo. Drug efflux activity increased after chemotherapy. Addition of R121 to chemotherapeutic regimens significantly reduced the proportions of tumor cells positive for MRPs in vitroandin vivo. Tumor size and prevalence of metastases decreased significantly compared to untreated controls. CONCLUSION: Beneficial effects of high-affinity peptide R121 on reversing chemotherapy-induced MDR were demonstrated in pancreatic cancer.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Reversin 121	P-glycoprotein 1	Protein	Humans	Yes	Inhibitor	Details